Skip to main content

Small-Molecule Screening Assay for Mono-ADP-Ribosyltransferases

  • Protocol
  • First Online:
ADP-ribosylation and NAD+ Utilizing Enzymes

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1813))

Abstract

Mono-ADP-ribosyltransferases of the PARP/ARTD enzyme family are enzymes catalyzing the transfer of a single ADP-ribose unit to target proteins. The enzymes have various roles in vital cellular processes such as DNA repair and transcription, and many of the enzymes are linked to cancer-relevant functions. Thus inhibition of the enzymes is a potential way to discover and develop new drugs against cancer. Here we describe an activity-based screening assay for mono-ADP-ribosyltransferases. The assay utilizes the natural substrate of the enzymes, NAD+, and it is based on chemically converting the leftover substrate to a fluorophore and measuring its relative concentration after the enzymatic reaction. The assay is homogenous, robust, and cost-effective and, most importantly, applicable to mono-ADP-ribosyltransferases as well as poly-ADP-ribosyltransferases for screening of small-molecule inhibitors against the enzymes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Schreiber V, Dantzer F, Ame J-C, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517–528

    Article  CAS  Google Scholar 

  2. Hottiger MO, Hassa PO, Lüscher B, Schüler H, Koch-Nolte F (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35:208–219

    Article  CAS  Google Scholar 

  3. Kleine H et al (2008) Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol Cell 32:57–69

    Article  CAS  Google Scholar 

  4. Gupte R, Liu Z, Kraus WL (2017) PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev 31:101–126

    Article  CAS  Google Scholar 

  5. Vyas S, Chang P (2014) New PARP targets for cancer therapy. Nat Rev Cancer 14:502–509

    Article  CAS  Google Scholar 

  6. Haikarainen T, Krauss S, Lehtiö L (2014) Tankyrases: structure, function and therapeutic implications in cancer. Curr Pharm Des 20:6472–6488

    Article  CAS  Google Scholar 

  7. Daniels CM, Ong S-E, Leung AKL (2015) The promise of proteomics for the study of ADP-ribosylation. Mol Cell 58:911–924

    Article  CAS  Google Scholar 

  8. Wahlberg E et al (2012) Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 30:283–288

    Article  CAS  Google Scholar 

  9. Peng B, Thorsell A-G, Karlberg T, Schüler H, Yao SQ (2017) Small molecule microarray based discovery of PARP14 inhibitors. Angew Chem Int Ed Engl 56:248–253

    Article  CAS  Google Scholar 

  10. Ekblad T et al (2015) Towards small molecule inhibitors of mono-ADP-ribosyltransferases. Eur J Med Chem 95:546–551

    Article  CAS  Google Scholar 

  11. Venkannagari H, Fallarero A, Feijs KLH, Lüscher B, Lehtiö L (2013) Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors. Eur J Pharm Sci 49:148–156

    Article  CAS  Google Scholar 

  12. Narwal M, Fallarero A, Vuorela P, Lehtiö L (2012) Homogeneous screening assay for human tankyrase. J Biomol Screen 17:593–604

    Article  CAS  Google Scholar 

  13. Putt KS, Hergenrother PJ (2004) An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Anal Biochem 326:78–86

    Article  CAS  Google Scholar 

  14. Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, Austin C, Baell J, Bejcek B, TDY C, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Hass JV, Inglese J, Iversen PW, Kahl SD, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr, Weidner JR, Xia M, Xu X (eds) (2004) Assay guidance manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lari Lehtiö .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Haikarainen, T., Murthy, S., Maksimainen, M.M., Lehtiö, L. (2018). Small-Molecule Screening Assay for Mono-ADP-Ribosyltransferases. In: Chang, P. (eds) ADP-ribosylation and NAD+ Utilizing Enzymes. Methods in Molecular Biology, vol 1813. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-8588-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8588-3_16

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-8587-6

  • Online ISBN: 978-1-4939-8588-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics